Alvotech ALVO
NASDAQ ALVO
$5.19 +0.00 (+0.00%)
As of: Sep 9, 2026 · 2:52 PM EDT

Alvotech (ALVO) Other Non Operating Income (2021 - 2026)

Alvotech's (ALVO) quarterly Other Non Operating Income came in at $2.4 million in Q2 2026, up 120.22% on a YoY basis from $1.1 million in Q2 2025, and up 283.55% quarter-over-quarter from -$1.3 million in Q1 2026.

Analysis

Alvotech (ALVO) Other Non Operating Income (2021 - 2026) Analysis & Trends

Alvotech (ALVO) has reported Other Non Operating Income for 6 consecutive years, with $2.4 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Other Non Operating Income rose 120.22% year-over-year to $2.4 million; the trailing twelve-month figure through Jun 2026 stood at -$20.1 million (up 87.88% YoY), and the FY2025 full-year result was -$16.8 million, up 75.73% from the prior year.
  • Other Non Operating Income rose to $2.4 million in Q2 2026 per ALVO's latest filing, from -$1.3 million in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $32.1 million in Q2 2022 and bottomed at -$77.1 million in Q3 2024.
  • Historically, Other Non Operating Income has averaged -$11.7 million across 5 years, with a median of -$4.1 million in 2023.
  • The widest YoY moves for Other Non Operating Income: up 226.03% in 2024, down 1238.57% in 2024.
  • Over 5 years, Other Non Operating Income stood at -$27.3 million in 2022, then surged by 81.02% to -$5.2 million in 2023, then slumped by 1238.57% to -$69.4 million in 2024, then jumped by 71.63% to -$19.7 million in 2025, then surged by 112.08% to $2.4 million in 2026.
  • According to Business Quant data, Other Non Operating Income over the past three periods registered $2.4 million, -$1.3 million, and -$19.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 42.56 Bn 38.90 Bn 2.15 Bn
2 Viatris 19.17 Bn 18.28 Bn 1.46 Bn
3 Dr Reddys Laboratories 9.88 Bn 9.71 Bn 396.53 Mn
4 Amneal Pharmaceuticals 5.47 Bn 5.35 Bn 334.51 Mn
5 Bausch Health Companies 2.35 Bn 507.63 Mn 2.10 Bn
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn
8 Amphastar Pharmaceuticals 996.39 Mn 706.27 Mn 93.47 Mn
9 Fennec Pharmaceuticals 401.41 Mn 360.16 Mn 17.15 Mn
10 RedHill Biopharma 176.59 Mn 176.59 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.38 Mn
Mar 31, 2026 -1.30 Mn
Dec 31, 2025 -19.68 Mn
Sep 30, 2025 -1.54 Mn
Jun 30, 2025 -11.75 Mn
Mar 31, 2025 -7.93 Mn
Dec 31, 2024 -69.38 Mn
Sep 30, 2024 -77.12 Mn
Jun 30, 2024 1.21 Mn
Mar 31, 2024 6.53 Mn
Dec 31, 2023 -5.18 Mn
Aug 31, 2023 -3.08 Mn
Jun 30, 2023 -1.33 Mn
Mar 20, 2023 -5.18 Mn
Dec 31, 2022 -27.31 Mn
Aug 31, 2022 4.74 Mn
Jun 30, 2022 32.06 Mn
Mar 20, 2022 -27.31 Mn
Dec 31, 2021 149.23 Mn